Glenmark Pharma and SaNOtize announce results of its phase-III clinical trials on SaNOtize’s Nitric Oxide nasal spray Read more
Glenmark inks agreement with SaNOtize to commercialise nasal spray for COVID-19 treatment in India and other Asian markets Read more
Glenmark Pharma and Menarini enter into exclusive licensing agreement for commercialising Ryaltris for European markets Read more